A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot

Quality of Life Research

Volumn 11, Issue 1, 2002, Pages 37-45

  Sloan, Jeff A ^a   Sargent, Daniel J ^a   Lindman, Jed ^a   Allmer, Cristine ^a   Vargas Chanes, Delfino ^a   Creagan, Edward T ^a   Bonner, James A ^b   O'Connell, Michael J ^a   Dalton, Robert J ^c   Rowland, Kendrith M ^d   Brooks, Burke J ^e   Laurie, John A ^f  

^a MAYO CLINIC   (United States)

^b The University of Alabama at Birmingham   (United States)

^c Duluth CCOP   (United States)

^d Carle Cancer Center CCOP   (United States)

^e Ochsner CCOP   (United States)

^f ALTRU HEALTH SYSTEM   (United States)

Author keywords

Kaplan Meier estimates; Q TWiST; Survival analysis

Indexed keywords

ALPHA2A INTERFERON;

ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MELANOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

COMPUTER GRAPHICS; HUMANS; INTERFERON ALFA-2A; MELANOMA; QUALITY-ADJUSTED LIFE YEARS; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036221470     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014401516011     Document Type: Article

References (16)

1. Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis
2. Modeling health-related quality of life: The bridge between psychometric and utility-based measures
3. Comparing treatment using quality adjusted survival: The Q-TWiST method
4. Measuring health state preferences and utilities: Rating scale, time trade-off, and standard gamble techniques
5. Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2a in selected patients with malignant melanoma
6. Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821
7. A quality-adjusted re-analysis of a phase III trial comparing once-daily thoracic radiation versus twice-daily thoracic radiation in patients with limited stage small cell lung cancer
8. A consistent estimator for the distribution of quality adjusted survival time
9. New York, USA: John Wiley & Sons
10. The danger of applying group-level utilities in decision analyses of the treatment of localized prostate cancer in individual patients
11. Whose utilities for decision analysis?
12. Decision analysis in locally advanced non-small-cell lung cancer: Is it useful?
13. Patients' utilities for cancer treatments: A study of the chained procedure for the standard gamble and time tradeoff
14. Utility assessment in cancer patients: Adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores
15. Patient participation in clinical decision-making for treatment of T3 laryngeal cancer: A comparison of state and process utilities